Pages that link to "Item:Q4842831"
From MaRDI portal
The following pages link to Practical Bayesian Guidelines for Phase IIB Clinical Trials (Q4842831):
Displayed 18 items.
- A review of phase 2-3 clinical trial designs (Q1029784) (← links)
- Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials (Q1727847) (← links)
- Control of type I error rates in Bayesian sequential designs (Q1738139) (← links)
- Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials (Q2059113) (← links)
- On a Type of Probability Stopping Rule for Toxicity Study (Q2941679) (← links)
- A Bayesian Decision Approach for Sample Size Determination in Phase II Trials (Q3078735) (← links)
- Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology (Q3078865) (← links)
- Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials (Q3078908) (← links)
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies (Q3079128) (← links)
- Designs for Single- or Multiple-Agent Phase I Trials (Q3445286) (← links)
- Generalized Likelihood Ratio Statistics and Uncertainty Adjustments in Efficient Adaptive Design of Clinical Trials (Q3527716) (← links)
- Bayesian Optimal Design for Phase II Screening Trials (Q3530110) (← links)
- Testing simultaneous hypotheses in pharmaceutical trials: a bayesian approach (Q4224608) (← links)
- MULTINOMIAL PHASE II CANCER TRIALS INCORPORATING RESPONSE AND EARLY PROGRESSION (Q4512728) (← links)
- Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes (Q4666685) (← links)
- Novel Bayesian Adaptive Designs and Their Applications in Cancer Clinical Trials (Q5050425) (← links)
- A hybrid Bayesian-frequentist predictive design for monitoring multi-stage clinical trials (Q5197969) (← links)
- An Introduction to Practical Sequential Inferences via Single-Arm Binary Response Studies Using the binseqtest R Package (Q5877675) (← links)